Trends in the Incidence, Organization of Care, and Surgical Treatment of Medullary Thyroid Cancer: A Population-Based Study.

Autor: Jager EC; Division of Surgical Oncology, Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Metman MJH; Division of Surgical Oncology, Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands., Timmenga IAC; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Zandee WT; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Jansen L; Division of Surgical Oncology, Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands., van Hemel BM; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands., Lodewijk L; Department of Endocrine Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., Vriens MR; Department of Endocrine Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., van den Broek MFM; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Engelsman AF; Department of Surgery, Location VUmc, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Dreijerink KMA; Department of Endocrinology and Metabolism, Location VUmc, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Netea-Maier RT; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands., van Ginhoven TM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Peeters RP; Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus Medical Center, Rotterdam, The Netherlands., de Heus E; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Links TP; Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Kruijff S; Division of Surgical Oncology, Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2024 Dec 20. Date of Electronic Publication: 2024 Dec 20.

Expression of integrin α v β 3 in medullary thyroid carcinoma.

Autor: de Vries LH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Lodewijk L; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Pijnappel EW; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Schepers A; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333, ZA Leiden, The Netherlands., Bonenkamp HJ; Department of Surgery, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., van Engen-van Grunsven IA; Department of Pathology, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., Kruijff S; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., van Hemel BM; Department of Pathology, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., Links TP; Department of Internal Medicine, University Medical Center Groningen, Hanzeplein 1, 9700. RB Groningen, The Netherlands., Nieveen van Dijkum EJ; Department of Surgery, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., van Eeden S; Department of Pathology, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., de Keizer B; Department of Radiology & Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Borel Rinkes IH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Vriens MR; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (27), pp. 2015-2022. Date of Electronic Publication: 2024 Aug 05.

Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center.

Autor: Piek MW; Departments of Surgical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands., de Vries LH; Departments of Surgery, University Medical Center of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Donswijk ML; Departments of Nuclear Medicine, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands., de Keizer B; Departments of Nuclear Medicine, University Medical Center of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., de Boer JP; Departments of Internal Medicine, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands., Lodewijk L; Departments of Surgery, University Medical Center of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., van Leeuwaarde RS; Departments of Endocrine Oncology, University Medical Center of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Vriens MR; Departments of Surgery, University Medical Center of Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Hartemink KJ; Departments of Surgical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands., van der Ploeg IMC; Departments of Surgical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX, Amsterdam, The Netherlands. i.vd.ploeg@nki.nl.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jun; Vol. 49 (7), pp. 2392-2400. Date of Electronic Publication: 2022 Jan 15.

Sentinel lymph node detection in thyroid carcinoma using ⁶⁸ Ga-tilmanocept PET/CT: a proof-of-concept study protocol.

Autor: de Vries LH; Department of Surgery, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands., Lodewijk L; Department of Surgery, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands., de Keizer B; Department of Radiology & Nuclear Medicine, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands., Borel Rinkes IH; Department of Surgery, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands., Vriens MR; Department of Surgery, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.

Publikováno v: Future oncology (London, England) [Future Oncol] 2022 Oct; Vol. 18 (31), pp. 3493-3499. Date of Electronic Publication: 2022 Sep 07.

FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels.

Autor: Lebbink CA; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital (WKZ), University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Vries LH; Department of Surgery, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Borel Rinkes IHM; Department of Surgery, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Braat AJAT; Department of Nuclear Medicine and Radiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Lodewijk L; Department of Surgery, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., van Treijen MJC; Department of Endocrine Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Vriens MR; Department of Surgery, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands., van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital (WKZ), University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Keizer B; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Nuclear Medicine and Radiology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2022 May 24; Vol. 187 (1), pp. 101-110. Date of Electronic Publication: 2022 May 24.